HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

denileukin diftitox (Ontak)

more potent, truncated form of DAB(486)-IL-2; inhibit HIV-1 RNA production in infected cells
Also Known As:
Ontak; DAB(389)-IL-2; DAB(389)-interleukin 2; DAB(389)IL-2; DAB389-IL-2; LY-335348
Networked: 120 relevant articles (25 outcomes, 34 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1. Duvic, Madeleine: 15 articles (11/2017 - 01/2002)
2. Dang, Nam H: 8 articles (01/2015 - 04/2004)
3. Foss, Francine: 8 articles (07/2011 - 12/2003)
4. Prince, H Miles: 5 articles (08/2013 - 05/2004)
5. Foss, Francine M: 5 articles (07/2013 - 03/2002)
6. Kreitman, Robert J: 5 articles (01/2009 - 02/2003)
7. Walker, Pamela L: 5 articles (08/2007 - 04/2004)
8. Curiel, Tyler J: 4 articles (01/2021 - 12/2005)
9. Goy, Andre: 4 articles (07/2013 - 10/2004)
10. Olsen, Elise A: 4 articles (03/2013 - 03/2002)

Related Diseases

1. Neoplasms (Cancer)
2. Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
3. Non-Hodgkin Lymphoma (Lymphosarcoma)
4. Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
5. Psoriasis (Pustulosis Palmaris et Plantaris)

Related Drugs and Biologics

1. denileukin diftitox (Ontak)
2. Proteins (Proteins, Gene)
3. Interleukin-2 (IL2)
4. Diphtheria Toxin
5. Vaccines
6. Vincristine (Oncovin)
7. Doxorubicin (Adriamycin)
8. Cyclophosphamide (Cytoxan)
9. Interleukin-2 Receptors (IL 2 Receptor)
10. Bexarotene (LGD1069)

Related Therapies and Procedures

1. Therapeutics
2. Drug Therapy (Chemotherapy)
3. Hematopoietic Stem Cell Transplantation
4. Radioimmunotherapy
5. Premedication